Form S-1/A CATALYST BIOSCIENCES,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
Catalyst Biosciences (CBIO) Prices Common Stock and Warrant Offering for Gross Proceeds of $18M
April 7, 2017 8:40 AM EDTCatalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the pricing of an underwritten public offering of units for gross proceeds of $18 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Catalyst.
The offering is comprised of Class A Units, priced at a public offering price of $5.00 per unit, with each unit consisting of one share of common stock and a five-year warrant (each, a warrant) to purchase one-half share of common stock with an... More
Catalyst Biosciences (CBIO) Set to Open Lower
April 7, 2017 6:46 AM EDTCatalyst Biosciences (NASDAQ: CBIO) was set to open sharply lower Friday morning following an effective notice from the SEC regarding its recent S-1.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Notice of EffectivenessEffectiveness Date:April 6, 2017 5:00 P.M.Form:S-1CIK:0001124105Company Name:CATALYST BIOSCIENCES, INC.File Number:333-216663... More